Company intelligence / Profile preview
Zhuzhou Qianjin Pharmaceutical Co., Ltd.
Zhuzhou, Hunan, Chinaqjyy.com ↗
- Ownership
- Private
- Employees
- ~5335
- Development stage
- Other
01
Overview
Zhuzhou Qianjin Pharmaceutical has a broad commercial portfolio with multiple approved products, especially in gynecology and chronic disease management. The company also maintains an active R&D pipeline with at least five herbal medicines and four small molecule drugs targeting nervous system, infectious, endocrine/metabolic disorders, among others. Several programs have reached approval status in China.
- Therapeutic areas
- EndocrinologyWomen's HealthCardiovascularNeurologyInfectious Diseases
- Modalities
- Small molecule drugsHerbal medicines
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Beyond the preview
Go deeper on Zhuzhou Qianjin Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhuzhou Qianjin Pharmaceutical Co., Ltd..